Avanza Fonder AB acquired a new stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 10,935 shares of the technology company’s stock, valued at approximately $2,299,000.
A number of other hedge funds also recently bought and sold shares of the business. Dimensional Fund Advisors LP grew its position in shares of Veeva Systems by 26.2% in the second quarter. Dimensional Fund Advisors LP now owns 378,380 shares of the technology company’s stock valued at $69,259,000 after purchasing an additional 78,654 shares in the last quarter. Amalgamated Bank grew its holdings in Veeva Systems by 2.1% in the 2nd quarter. Amalgamated Bank now owns 9,968 shares of the technology company’s stock valued at $1,824,000 after buying an additional 201 shares in the last quarter. Vanguard Personalized Indexing Management LLC increased its stake in shares of Veeva Systems by 8.6% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 10,388 shares of the technology company’s stock worth $1,901,000 after acquiring an additional 819 shares during the last quarter. Hsbc Holdings PLC raised its holdings in shares of Veeva Systems by 30.7% during the 2nd quarter. Hsbc Holdings PLC now owns 148,502 shares of the technology company’s stock worth $27,202,000 after acquiring an additional 34,896 shares during the period. Finally, GM Advisory Group LLC grew its holdings in shares of Veeva Systems by 20.8% in the second quarter. GM Advisory Group LLC now owns 1,219 shares of the technology company’s stock valued at $223,000 after purchasing an additional 210 shares during the period. Institutional investors and hedge funds own 88.20% of the company’s stock.
Veeva Systems Trading Up 0.9 %
Shares of NYSE:VEEV opened at $216.67 on Friday. Veeva Systems Inc. has a 52 week low of $170.25 and a 52 week high of $258.93. The company’s 50 day moving average is $222.31 and its two-hundred day moving average is $209.47. The company has a market cap of $35.18 billion, a PE ratio of 53.50, a P/E/G ratio of 1.91 and a beta of 0.84.
Insider Activity at Veeva Systems
Analyst Upgrades and Downgrades
A number of brokerages have commented on VEEV. Needham & Company LLC reaffirmed a “buy” rating and set a $270.00 target price on shares of Veeva Systems in a research note on Friday. Guggenheim upped their price objective on Veeva Systems from $233.00 to $249.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. Royal Bank of Canada raised their target price on Veeva Systems from $275.00 to $285.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Piper Sandler lifted their target price on Veeva Systems from $280.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Finally, Robert W. Baird increased their price target on Veeva Systems from $275.00 to $283.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and nineteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $255.74.
View Our Latest Analysis on VEEV
Veeva Systems Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- Overbought Stocks Explained: Should You Trade Them?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Market Cap Calculator: How to Calculate Market Cap
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- MarketBeat Week in Review – 01/13 – 01/17
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.